Clovis short sellers undaunted as stock price surges

NEW YORK (Reuters) - Clovis Oncology Inc's share price has doubled in the past month, fueled by positive developments for the company's experimental cancer drug and takeover speculation. But some investors also appear to be increasing bets against the stock.